Brief: IRLAB Q2 Sales SEK 42.8 Million
10/07/2024 06:00
Jul 10 (Reuters) - IRLAB Q2 operating cash flow SEK -100 thousand. * Q2 adjusted EPS SEK -0.14 * Q2 EBIT SEK -5.1 million
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK165.12m
- SEK155.10m
- SEK57.46m